This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
However, researchers said the drug may be helpful in reducing heartfailure risks, including hospitalization, following a heartattack. However, researchers said the drug may be helpful in reducing heartfailure risks, including hospitalization, following a heartattack.
While composite of death and heartfailure hospitalizations was not significantly reduced, empagliflozin may help reduce heartfailure risks after a heartattack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24,
This condition, known as left ventricular hypertrophy, can lead to heartfailure if untreated. This condition, called atherosclerosis, narrows the arteries, restricting blood flow and increasing the risk of heartattacks and strokes. If an aneurysm ruptures, it can cause life-threatening internal bleeding.
Today’s vlog is on the subject of heartfailure and in particular on a special type of pacemaker which can make a significant improvement to the quality of life and length of life in patients with heartfailure. What is heartfailure?
Today’s video is on the subject of heartfailure. Heartfailure is a chronic clinical syndrome characterised by the inability of the heart to pump out enough blood to meet the body’s requirements. Anything that affects the heart in a bad way may in its severest form lead to heartfailure.
If the inflammation spreads to the surface of the heart itself, it is termed myopericarditis. About 5% of patients who present to A+E with chest pain which is not deemed to be a heartattack or angina are ultimately diagnosed with pericarditis. Also recent cardiac surgery and a recent heartattack can present with pericarditis.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content